Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antisense oligonucleotides: from design to therapeutic application.

Jasmine H P Chan1, Shuhui Lim, W S Fred Wong

  • 1Department of Pharmacology, Yong Loo Lin School of Medicine and Immunology Program, National University of Singapore, Singapore.

Clinical and Experimental Pharmacology & Physiology
|May 17, 2006
PubMed
Summary

Antisense oligonucleotides (ASOs) are short DNA analogues that target specific mRNA to control protein expression. This review covers ASO design, delivery, and clinical applications for treating diseases.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Characterization of humoral and cellular immunity induced by mRNA vaccines expressing norovirus VP1 proteins in mice and NHPs.

Molecular therapy : the journal of the American Society of Gene Therapy·2025
Same author

Resolution of innate immune cells with proresolving lipid mediators in idiopathic pulmonary fibrosis.

Journal of leukocyte biology·2025
Same author

Formoterol, the Most Effective Bronchodilator, Has No Anti-Inflammatory nor Metabolic Modulatory Effects in Severe Asthma Induced by Aspergillus fumigatus.

ACS pharmacology & translational science·2025
Same author

Discovery of an NF-κB1 p105 Degrader for Anti-Inflammatory Therapy via Structural Optimization of the Coumarin Natural Product Minutuminolate.

Journal of medicinal chemistry·2025
Same author

Calcaratarin D, a labdane diterpenoid, attenuates bleomycin-induced pulmonary fibrosis by blocking Wnt/β-catenin signaling pathway.

Pharmacological research·2025
Same author

A combination of alveolar type 2-specific p38α activation with a high-fat diet increases inflammatory markers in mouse lungs.

The Journal of biological chemistry·2025

Area of Science:

  • Molecular Biology
  • Biotechnology
  • Drug Discovery

Background:

  • Antisense oligonucleotides (ASOs) are short nucleotide sequences designed to bind messenger RNA (mRNA) through Watson-Crick base pairing.
  • This hybridization can lead to mRNA degradation, inhibit protein translation, or interfere with mRNA processing, ultimately downregulating target protein expression.

Purpose of the Study:

  • To provide a comprehensive overview of antisense oligonucleotide (ASO) technology.
  • To discuss the rational design, chemical modifications, delivery systems, and toxicology of ASOs.
  • To survey current clinical studies involving ASO therapeutics.

Main Methods:

  • Review of theoretical approaches for ASO design.
  • Analysis of chemical modifications to enhance ASO properties.

Related Experiment Videos

  • Examination of various ASO delivery strategies.
  • Survey of ASO-related toxicology and clinical trial data.

    • Main Results:

    • ASOs serve as valuable tools for experimental validation of protein targets.
    • ASOs represent a highly selective therapeutic strategy for diseases characterized by dysregulated protein expression.
    • The review details multiple mechanisms by which ASOs modulate gene expression.

    Conclusions:

    • ASO technology offers a versatile platform for both research and therapeutic applications.
    • Understanding ASO design, delivery, and safety is crucial for advancing their clinical use.
    • ASOs are emerging as a promising class of drugs for various human diseases.